DEA LIVE Hearings On Marijuana Rescheduling, What To Expect
The Drug Enforcement Administration (DEA) launched its inaugural hearing on Monday December 2, 2024, to address the Biden administration’s proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
According to a DEA advisory released on November 26, the primary goal is to organize the procedural groundwork for addressing the merits of rescheduling.
While this initial meeting is procedural, it sets the stage for a series of substantive discussions slated for 2025 that could redefine the landscape of cannabis regulation in the United States.
A Procedural Step Towards Reform
The meeting, held at DEA headquarters in Arlington, Virginia, is not to take witness testimony but instead is focusing on logistical matters, including scheduling and legal frameworks for future evidentiary hearings. The judge will question Some witnesses proposed by representatives, particularly “experts.”
In-person attendance is restricted to designated participants and pre-approved media representatives, with public access available via a livestream on the DEA’s website. You can follow the hearing via this link:
Implications Of Rescheduling
Reclassifying cannabis to Schedule …